- cafead   Mar 04, 2024 at 11:22: AM
via Cancer drug developer FogPharma has raised $145 million in fresh funding, the company revealed Friday, announcing a Series E round that will give a financial boost to the nearly decade-old biotechnology company.
article source
article source